James Annis

1.4k total citations · 1 hit paper
16 papers, 1.0k citations indexed

About

James Annis is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, James Annis has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in James Annis's work include Ubiquitin and proteasome pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Pluripotent Stem Cells Research (2 papers). James Annis is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Pluripotent Stem Cells Research (2 papers). James Annis collaborates with scholars based in United States, South Africa and India. James Annis's co-authors include David J. Rawlings, Michael T. Certo, Jordan Jarjour, Andrew M. Scharenberg, Byoung Y. Ryu, Peter S. Linsley, Carla Grandori, Randall T. Moon, Jason P. Frazier and Michele A. Cleary and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

James Annis

16 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping

2018 329 citations Stefan Czerniecki, Nelly M. Cruz et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Annis United States	9	869	246	126	125	123	16	1.0k
Alexandros Strikoudis United States	13	587 0.7×	184 0.7×	188 1.5×	50 0.4×	58 0.5×	13	887
Pavlova Tv Russia	19	657 0.8×	216 0.9×	130 1.0×	37 0.3×	79 0.6×	47	947
Jesse L. Cox United States	18	677 0.8×	362 1.5×	101 0.8×	62 0.5×	70 0.6×	50	1.1k
Dorian Korz United States	10	710 0.8×	295 1.2×	137 1.1×	32 0.3×	119 1.0×	11	1.2k
Sergio Ménendez United Kingdom	13	1.2k 1.4×	343 1.4×	38 0.3×	89 0.7×	86 0.7×	15	1.3k
Lingtao Wu United States	19	716 0.8×	333 1.4×	150 1.2×	34 0.3×	202 1.6×	34	1000
Karen D. Cowden Dahl United States	15	678 0.8×	277 1.1×	93 0.7×	63 0.5×	70 0.6×	26	1.1k
Elena Nardini Italy	11	1.1k 1.3×	508 2.1×	63 0.5×	70 0.6×	125 1.0×	18	1.7k
Tracy G. Ram United States	9	481 0.6×	433 1.8×	60 0.5×	124 1.0×	140 1.1×	12	917
Yaser Atlasi Netherlands	16	1.3k 1.5×	288 1.2×	66 0.5×	36 0.3×	106 0.9×	29	1.5k

Countries citing papers authored by James Annis

Since Specialization

Citations

This map shows the geographic impact of James Annis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Annis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Annis more than expected).

Fields of papers citing papers by James Annis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Annis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Annis. The network helps show where James Annis may publish in the future.

Co-authorship network of co-authors of James Annis

This figure shows the co-authorship network connecting the top 25 collaborators of James Annis. A scholar is included among the top collaborators of James Annis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Annis. James Annis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Moser, Russell, James Annis, Olga Nikolova, et al.. (2022). Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL. Cancer Research. 82(18). 3375–3393. 4 indexed citations

Stanton, Sasha E., Ekram Gad, James Annis, et al.. (2021). Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients. npj Breast Cancer. 7(1). 50–50. 7 indexed citations

Robinson, Kristin, et al.. (2020). Characterization of GRK5 as a novel regulator of rhabdomyosarcoma tumor cell growth and self-renewal. Oncotarget. 11(16). 1448–1461. 4 indexed citations

Zhang, Jiaming, Nikolay Burnaevskiy, James Annis, et al.. (2020). Cell-to-Cell Variation in Gene Expression for Cultured Human Cells Is Controlled in Trans by Diverse Genes: Implications for the Pathobiology of Aging. The Journals of Gerontology Series A. 75(12). 2295–2298. 3 indexed citations

Zhang, Jiaming, et al.. (2019). Inactivating Mutations in Exonuclease and Polymerase Domains in DNA Polymerase Delta Alter Sensitivities to Inhibitors of dNTP Synthesis. DNA and Cell Biology. 39(1). 50–56. 5 indexed citations

Czerniecki, Stefan, Nelly M. Cruz, Jennifer L. Harder, et al.. (2018). High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping. Cell stem cell. 22(6). 929–940.e4. 329 indexed citations breakdown →

Chien, Sylvia, James Annis, Jin Dai, et al.. (2018). High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia. Blood. 132(Supplement 1). 180–180. 3 indexed citations

Liu, Jing, Lin Xu, James Annis, et al.. (2016). Negative regulation of initial steps in skeletal myogenesis by mTOR and other kinases. Scientific Reports. 6(1). 20376–20376. 4 indexed citations

Moser, Russell, Chang Xu, Michael Kao, et al.. (2014). Functional Kinomics Identifies Candidate Therapeutic Targets in Head and Neck Cancer. Clinical Cancer Research. 20(16). 4274–4288. 66 indexed citations

10.

Bluemn, Eric G., Brigham H. Mecham, Ryan R. Gordon, et al.. (2013). PPP2R2C Loss Promotes Castration-Resistance and Is Associated with Increased Prostate Cancer-Specific Mortality. Molecular Cancer Research. 11(6). 568–578. 36 indexed citations

11.

Broussard, Elizabeth K., Rachel Kim, Jesse C. Wiley, et al.. (2013). Identification of Putative Immunologic Targets for Colon Cancer Prevention Based on Conserved Gene Upregulation from Preinvasive to Malignant Lesions. Cancer Prevention Research. 6(7). 666–674. 23 indexed citations

12.

Toyoshima, Masafumi, Heather L. Howie, Ryan Walsh, et al.. (2012). Functional genomics identifies therapeutic targets for MYC-driven cancer. Proceedings of the National Academy of Sciences. 109(24). 9545–9550. 197 indexed citations

13.

Certo, Michael T., Byoung Y. Ryu, James Annis, et al.. (2011). Tracking genome engineering outcome at individual DNA breakpoints. Nature Methods. 8(8). 671–676. 231 indexed citations

14.

Klinghoffer, Richard A., Jason P. Frazier, James Annis, et al.. (2009). A Lentivirus-Mediated Genetic Screen Identifies Dihydrofolate Reductase (DHFR) as a Modulator of β-Catenin/GSK3 Signaling. PLoS ONE. 4(9). e6892–e6892. 16 indexed citations

15.

Klinghoffer, Richard A., Brian S. Roberts, James Annis, et al.. (2008). An Optimized Lentivirus-Mediated RNAi Screen Reveals Kinase Modulators of Kinesin-5 Inhibitor Sensitivity. Assay and Drug Development Technologies. 6(1). 105–119. 8 indexed citations

16.

Carleton, Michael, Mao Mao, Matthew C. Biery, et al.. (2006). RNA Interference-Mediated Silencing of Mitotic Kinesin KIF14 Disrupts Cell Cycle Progression and Induces Cytokinesis Failure. Molecular and Cellular Biology. 26(10). 3853–3863. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact